The tryptophan system in cocaine-induced depression

Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. Thi...

Descripción completa

Detalles Bibliográficos
Autores: Fonseca Casals, Francina, 1972-, Mestre-Pintó, Juan Ignacio, Gómez-Gómez, Àlex, Martínez-Sanvisens, Diana, Rodríguez-Minguela, Rocío, Papaseit Fontanet, Esther, Pérez Mañá, Clara, Langohr, Klaus, Valverde Granados, Olga, Pozo Mendoza, Óscar J., 1975-, Farré Albaladejo, Magí, Neurodep Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/48696
Acceso en línea:http://hdl.handle.net/10230/48696
http://dx.doi.org/10.3390/jcm9124103
Access Level:acceso abierto
Palabra clave:Cocaine use disorder
Kynurenine
Primary/substance-induced depression
Serotonin
Tryptophan
id ES_c4b62364555e4b8fc86d16a6748a8da4
oai_identifier_str oai:repositori.upf.edu:10230/48696
network_acronym_str ES
network_name_str España
repository_id_str
spelling The tryptophan system in cocaine-induced depressionFonseca Casals, Francina, 1972-Mestre-Pintó, Juan IgnacioGómez-Gómez, ÀlexMartínez-Sanvisens, DianaRodríguez-Minguela, RocíoPapaseit Fontanet, EstherPérez Mañá, ClaraLangohr, KlausValverde Granados, OlgaPozo Mendoza, Óscar J., 1975-Farré Albaladejo, MagíPérez Mañá, ClaraNeurodep GroupCocaine use disorderKynureninePrimary/substance-induced depressionSerotoninTryptophanMajor depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach.This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010, RD16/0017/0003; Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI14/00178, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS) (SLT006/17/00014); and Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R). The funding agencies had no role in study design, data collection, interpretation, or had influence on the writing.MDPI202120212020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/48696http://dx.doi.org/10.3390/jcm9124103reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésinfo:eu-repo/grantAgreement/ES/1PE/MTM2015-64465-C2-1-RCopyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/486962026-06-12T07:21:37Z
dc.title.none.fl_str_mv The tryptophan system in cocaine-induced depression
title The tryptophan system in cocaine-induced depression
spellingShingle The tryptophan system in cocaine-induced depression
Fonseca Casals, Francina, 1972-
Cocaine use disorder
Kynurenine
Primary/substance-induced depression
Serotonin
Tryptophan
title_short The tryptophan system in cocaine-induced depression
title_full The tryptophan system in cocaine-induced depression
title_fullStr The tryptophan system in cocaine-induced depression
title_full_unstemmed The tryptophan system in cocaine-induced depression
title_sort The tryptophan system in cocaine-induced depression
dc.creator.none.fl_str_mv Fonseca Casals, Francina, 1972-
Mestre-Pintó, Juan Ignacio
Gómez-Gómez, Àlex
Martínez-Sanvisens, Diana
Rodríguez-Minguela, Rocío
Papaseit Fontanet, Esther
Pérez Mañá, Clara
Langohr, Klaus
Valverde Granados, Olga
Pozo Mendoza, Óscar J., 1975-
Farré Albaladejo, Magí
Pérez Mañá, Clara
Neurodep Group
author Fonseca Casals, Francina, 1972-
author_facet Fonseca Casals, Francina, 1972-
Mestre-Pintó, Juan Ignacio
Gómez-Gómez, Àlex
Martínez-Sanvisens, Diana
Rodríguez-Minguela, Rocío
Papaseit Fontanet, Esther
Pérez Mañá, Clara
Langohr, Klaus
Valverde Granados, Olga
Pozo Mendoza, Óscar J., 1975-
Farré Albaladejo, Magí
Neurodep Group
author_role author
author2 Mestre-Pintó, Juan Ignacio
Gómez-Gómez, Àlex
Martínez-Sanvisens, Diana
Rodríguez-Minguela, Rocío
Papaseit Fontanet, Esther
Pérez Mañá, Clara
Langohr, Klaus
Valverde Granados, Olga
Pozo Mendoza, Óscar J., 1975-
Farré Albaladejo, Magí
Neurodep Group
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Cocaine use disorder
Kynurenine
Primary/substance-induced depression
Serotonin
Tryptophan
topic Cocaine use disorder
Kynurenine
Primary/substance-induced depression
Serotonin
Tryptophan
description Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach.
publishDate 2020
dc.date.none.fl_str_mv 2020
2021
2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/48696
http://dx.doi.org/10.3390/jcm9124103
url http://hdl.handle.net/10230/48696
http://dx.doi.org/10.3390/jcm9124103
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv info:eu-repo/grantAgreement/ES/1PE/MTM2015-64465-C2-1-R
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418925901479937
score 15,811543